Clinical Updates & Treatment Advances in Metastatic Cervical Cancer from SGO
SGO 2022 Phase II Trial of Maintenance Niraparib in Stage III/IV or Platinum-Sensitive Recurrent Uterine Serous Carcinoma
By
SGO 2022 Conference Coverage on VuMedi
FEATURING
Marina Frimer
By
SGO 2022 Conference Coverage on VuMedi
FEATURING
Marina Frimer
Login to view comments.
Click here to Login
Clinical Updates & Treatment Advances in Metastatic Cervical Cancer from SGO